diseases, is pleased to announce that the first participant has been dosed in Regimen I of the HEALEY ALS Platform Trial evaluating Neurizon's lead candidate, NUZ-001, for the treatment of amyotrophic lateral sclerosis (ALS). HEALEY ALS Platform...
as Active Chairman of the Board of Directors. Mr. Mayron's appointment follows shareholder approval and submission of his formal Director Eligibility Declaration in accordance with the Israeli Companies Law. Extensive Leadership and Industry...
antibodies in humans. The model allows scientists to rank different antibody candidates by how they are likely to perform, measure how effectively they target specific immune cells, and evaluate their potential to slow disease progression. This...
several assays using capillary blood microsamples, which are collected using the Tasso device, and will serve as the performing laboratory of the combined service. The new partnership with Tasso is an additional element of ARUP's robust offerings...
developing innovative technologies and products based on its proprietary recombinant human collagen (rhCollagen) platform, today announced the launch of BioFlex, a ready-to-print rhCollagen-based kit designed for Digital Light Processing (DLP) 3D...
enable disease researchers to move beyond canonical protein lists toward biologically or pathologically functional proteoforms and PTM-resolved peptide variants. New releases in Bruker ProteoScape™, OmniScape™, and GlycoScape™ software now support...
The most recent data released from the Co-PSMA study clearly establishes that 64Cu-SAR-bisPSMA considerably outperforms its competitors in detecting prostate cancer recurrence and sheds light on the importance of the improved lesion detection,...
PureTech Health plc a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, announced that the U.S. Food and Drug Administration (FDA) and European Commission have granted Orphan Drug...
& Decision Modelling, who will lead evidence synthesis, advanced statistical analysis, and economic modelling that inform market access and Health Technology Appraisal (HTA) decision making within the Access Consulting and Health Economics and...
studies. This is a significant finding for patients, as it offers a potentially reliable strategy for providers and transformative opportunity for patients to manage their IBD journey even when treatment is interrupted.” “In clinical practice,...
factory for drug discovery programs, integrating a chemical compound repository with a high-throughput screening (HTS) platform. Its mission is to act as a bridge between academic research and pharmaceutical development, with a particular focus on...
in vitro and in vivo models into clinical studies. Their 30 years of foundational research now provide a robust platform for launching a new generation of anticancer treatments based on isotopic modulation. HYD LLC is actively seeking investment...
life-changing therapies wherever patients are treated. This clearance aligns with our strategy to extend the Freedom platform to more drug therapies, more settings, and more patients.” KORU Medical’s Freedom Infusion System enables, simplifies, and...
M.D. highlight TONMYA'S role as a centrally-acting, differentiated non-opioid treatment. TONMYA'S unique sublingual formulation is designed for bedtime administration and to bypass first-pass metabolism, resulting in a pharmacokinetic profile that...
the European Association for the Study of the Liver (EASL) consistently identify HDV–HBV co-infection as the most severe form of chronic viral hepatitis due to rapid progression towards liver cirrhosis, hepatocellular carcinoma and liver-related...
company developing localized therapies for solid tumors using its proprietary nanoengineered delivery platform, focused on improving outcomes while preserving quality of life. For more information please visit, www.privotechnologies.com
development and manufacturing services, including cell line development, process and bioassay development, drug product formulation development, and GMP manufacturing. The collaboration is designed to accelerate clinical translation, enhance CMC...
access to specialized in-person providers. As part of the New Year's expansion, CoreAge Rx is enhancing its digital platform, strengthening patient education resources, and optimizing fulfillment processes to ensure consistent medication...
cleansing agent, proudly announces the launch of Retaine® Omega Forté™, a highly purified omega-3 nutritional supplement formulated to provide superior support for individuals suffering from dry eye symptoms. Formulated with patient compliance and...
liposuction, sclerotherapy, and dermal fillers, and includes: Advanced Bruise Cream: A clinically proven, proprietary formula designed to accelerate skin healing and minimize bruising. Enriched with Arnica, Vitamin K, Emu Oil, Vitamin E, and Green...